Thiel-Sen regression | |||||
---|---|---|---|---|---|
Group | Participant | Slope | SE | z | p |
High dose | P1 | 0.33 | 0.12 | 2.84 | 0.005* |
P5 | 1.69 | 0.73 | 2.32 | 0.020* | |
P9 | 1.28 | 0.42 | 3.05 | 0.002* | |
P18 | 0.26 | 0.16 | 1.61 | 0.108 | |
P21 | 0.25 | 0.10 | 2.43 | 0.015* | |
P22 | 0.14 | 0.05 | 3.05 | 0.002* | |
P25 | 0.00 | 0.00 | 0.08 | 0.934 | |
P27 | 0.41 | 0.26 | 1.61 | 0.108 | |
P34 | − 0.15 | 0.20 | − .74 | 0.458 | |
P37 | 1.50 | 0.51 | 2.92 | 0.003* | |
Low dose | P2 | 0.77 | 0.82 | 0.94 | 0.348 |
P6 | − 2.43 | 1.45 | − 1.67 | 0.095 | |
P12 | − 0.23 | 0.75 | − 0.31 | 0.755 | |
P13 | 0.82 | 0.41 | 1.98 | 0.048* | |
P14 | − 0.33 | 0.20 | − 1.67 | 0.095 | |
P15 | 0.89 | 0.45 | 1.98 | 0.048* | |
P17 | 0.46 | 0.49 | 0.94 | 0.348 | |
P30 | 0.60 | 0.22 | 2.71 | 0.007* | |
P33 | − 0.25 | 0.13 | − 1.88 | 0.061 | |
P40 | 0.25 | 0.20 | 1.25 | 0.211 |